Partilhar
Informação da revista
Editorial
Desenvolvimento (pós‐Covid): memória, discernimento, humanismo, ética, ciência e natureza
António Bagão Félix
Rev Port Cardiol. 2021;40:311-5
Open access
Artigos originais
Surviving cardiac arrest: What happens after admission to the intensive care unit?
Raquel Menezes Fernandes, Daniel Nuñez, Nuno Marques, Cláudia Camila Dias, Cristina Granja
Rev Port Cardiol. 2021;40:317-25
Open access
Artigos Originais
Comentário editorial
Surviving a cardiac arrest: need for action now!
Doroteia Silva
Rev Port Cardiol. 2021;40:327-8
Open access
Artigos Originais
End commentary
MONITORIA: The start of a new era of ambulatory heart failure monitoring? Part I – Theoretical Rationale
Carla Martins, José Machado da Silva, Diana Guimarães, Luís Martins, Manuel Vaz da Silva
Rev Port Cardiol. 2021;40:329-37
Open access
Artigos Originais
Comentário editorial
Wearable remote monitoring in heart failure care – where do we stand?
Sofia Cabral
Rev Port Cardiol. 2021;40:339-41
Open access
Artigos Originais
End commentary
MONITORIA: The start of a new era of ambulatory heart failure monitoring? Part II – Design
Carla Martins, José Machado da Silva, Diana Guimarães, Luís Martins, Manuel Vaz Da Silva
Rev Port Cardiol. 2021;40:343-51
Open access
Artigos Originais
Comentário editorial
Remote monitoring of heart failure patients: A complex proximity
Dulce Brito
Rev Port Cardiol. 2021;40:353-6
Open access
Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke
Luís Paiva, José Coelho, Sérgio Barra, Marco Costa, João Sargento-Freitas, Luís Cunha, Lino Gonçalves
Rev Port Cardiol. 2021;40:357-65
Open access
Artigos Originais
Comentário editorial
O meu doente não pode, não quer ou não cumpre a anticoagulação oral. Cruzo os dedos ou cruzo o septo?
Rui Campante Teles
Rev Port Cardiol. 2021;40:367-9
Open access
Estado da arte
Tratamento não farmacológico da angina refratária. Dispositivo de redução do seio coronário, uma nova alternativa terapêutica
Sérgio Madeira, Catarina Brízido, Luís Raposo, João Brito, Nélson Vale, Sílvio Leal, Pedro de Araújo Gonçalves, Henrique Mesquita Gabriel, ... Manuel Almeida
Rev Port Cardiol. 2021;40:371-82
Open access
Caso clínico
Uma causa reversível de disfunção ventricular esquerda: caso clínico e breve revisão
David Roque, Daniel Faria, João Ferreira, Hilaryano Ferreira, Marco Beringuilho, Pedro Magno, Carlos Morais
Rev Port Cardiol. 2021;40:383-8
Open access
Imagens em cardiologia
Analysis of wall thickness to help identify critical isthmuses during ventricular tachycardia ablation
Raphaël P. Martins, Vincent Galand, Dominique Pavin
Rev Port Cardiol. 2021;40:389-90
Open access
Cartas ao editor
Cochrane Corner: Withdrawal of antihypertensive drugs in older people
Filipa Reis, Mariana Alves, Daniel Caldeira
Rev Port Cardiol. 2021;40:391-3
Open access
A rare cause of non-infectious sialadenitis: Iodide-induced sialadenitis associated with coronary angiography
Eduardo Flores-Umanzor, Margarida Pujol-Lopez, Pedro Cepas, Guillem Caldentey, Xavier Freixa, Victoria Martin-Yuste, Marta Farrero, Rosario J. Perea, ... Monica Masotti
Rev Port Cardiol. 2021;40:395-7
Open access
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.